Ensure Cardiac Resynchronization Therapy Study
Completed
Conditions studied: Heart Failure
In brief
The purpose of this study is to gather information on how doctors program particular settings on cardiac resynchronization therapy implantable cardiac defibrillators (CRT-Ds), to analyze how these settings affect the amount of cardiac resynchronization therapy (CRT) patients receive and to evaluate the therapy approach for converting abnormally fast heartbeats into normal heartbeats. There are no experimental devices or procedures involved in this study.
Key facts
- Study ID
- NCT00291564
- Run by
- Medtronic Cardiac Rhythm and Heart Failure
- People needed
- 430
- Starts
- 2004-05-01
- Expected to finish
- 2006-02-01
- Last updated by the study team
- 2007-12-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient is indicated for a Medtronic CRT-D system
- Patient is willing to sign Permission for Access to and Use of Health Information form
- Patient is willing and able to comply with follow-up visits through six months
You may not qualify if…
- Patient has a life expectancy of less than 6 months
- Patient is participating in any concurrent study that could confound the results for either study
Where it is running
- Study site — Birmingham, Alabama, United States
- Study site — Newport Beach, California, United States
- Study site — Trumbull, Connecticut, United States
- Study site — Daytona Beach, Florida, United States
- Study site — Augusta, Georgia, United States
- Study site — Kankakee, Illinois, United States
- Study site — Indianapolis, Indiana, United States
- Study site — Des Moines, Iowa, United States
- Study site — Owensboro, Kentucky, United States
- Study site — New Orleans, Louisiana, United States
- Study site — Salisbury, Maryland, United States
- Study site — Burlington, Massachusetts, United States
- Study site — Detroit, Michigan, United States
- Study site — Traverse City, Michigan, United States
- Study site — Minneapolis, Minnesota, United States
- Study site — Mexico, Missouri, United States
- Study site — Omaha, Nebraska, United States
- Study site — Bridgewater, New Jersey, United States
- Study site — Englewood, New Jersey, United States
- Study site — Charlotte, North Carolina, United States
- Study site — Dayton, Ohio, United States
- Study site — Lyndhurst, Ohio, United States
- Study site — Oklahoma City, Oklahoma, United States
- Study site — Portland, Oregon, United States
- Study site — Abington, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.